Literature DB >> 11368785

Modifications of eukaryotic initiation factor 4F (eIF4F) in adult cardiocytes by adenoviral gene transfer: differential effects on eIF4F activity and total protein synthesis rates.

A N Saghir1, W J Tuxworth , C H Hagedorn, P J McDermott.   

Abstract

In adult feline cardiocytes, increases in eukaryotic initiation factor 4F (eIF4F) activity are correlated with accelerated rates of total protein synthesis produced in response to increased load. Adenoviral gene transfer was employed to increase either eIF4F complex formation or the phosphorylation of eIF4E on Ser-209. To simulate load,cardiocytes were electrically stimulated to contract (2 Hz,5 ms pulses). Non-stimulated cardiocytes were used as controls.Adenovirus-mediated overexpression of wild-type eIF4E increased the total eIF4E pool by 120-140% above endogenous levels after 24 h and produced a corresponding increase in eIF4F content.However, it did not accelerate total protein synthesis rates inquiescent cardiocytes; neither did it potentiate the increase produced by contraction. To modify the affinity of eIF4F, cardiocytes were infected with a mutant (eIF4E/W56F) with a decreased binding affinity for the mRNA cap. Overexpression of eIF4E/W56F increased the quantity of eIF4F but the rate of total protein synthesis was decreased inquiescent and contracting cardiocytes. Overexpression of a mutant that blocked eIF4E phosphorylation (eIF4E/S209A) increased the quantity ofeIF4F without any significant effect on total protein synthesis rates in quiescent or contracting cardiocytes. Overexpression of the eIF4Ekinase Mnk-1 increased eIF4E phosphorylation without a corresponding increase in eIF4F complex formation or in the rate of total protein synthesis. We conclude the following: (1) eIF4F assembly is increased by raising eIF4E levels via adenoviral gene transfer; (2) the capbinding affinity of eIF4F is a rate-limiting determinant for total protein synthesis rates; and (3) increases in the quantity of eIF4Falone or in eIF4E phosphorylation are not sufficient to accelerate total protein synthesis rates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368785      PMCID: PMC1221869          DOI: 10.1042/0264-6021:3560557

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

Review 1.  Translational control in mammalian cells.

Authors:  J W Hershey
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

2.  Efficiency and capacity of protein synthesis are increased in pressure overload cardiac hypertrophy.

Authors:  R Nagai; R B Low; W S Stirewalt; N R Alpert; R Z Litten
Journal:  Am J Physiol       Date:  1988-08

Review 3.  Cardiocyte adaptation to chronically altered load.

Authors:  G Cooper
Journal:  Annu Rev Physiol       Date:  1987       Impact factor: 19.318

4.  Wall stress and patterns of hypertrophy in the human left ventricle.

Authors:  W Grossman; D Jones; L P McLaurin
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

5.  Role of load in regulating eIF-4F complex formation in adult feline cardiocytes.

Authors:  W J Tuxworth; H Wada; Y Ishibashi; P J McDermott
Journal:  Am J Physiol       Date:  1999-10

6.  Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus.

Authors:  L A Kirshenbaum; W R MacLellan; W Mazur; B A French; M D Schneider
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

7.  Novel phosphorylation sites of eukaryotic initiation factor-4F and evidence that phosphorylation stabilizes interactions of the p25 and p220 subunits.

Authors:  X Bu; D W Haas; C H Hagedorn
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

8.  The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins.

Authors:  S Mader; H Lee; A Pause; N Sonenberg
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

9.  Left ventricular hypertrophy due to volume overload versus pressure overload.

Authors:  B A Carabello; M R Zile; R Tanaka; G Cooper
Journal:  Am J Physiol       Date:  1992-10

10.  Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E.

Authors:  A Haghighat; S Mader; A Pause; N Sonenberg
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

View more
  6 in total

1.  Proteins regulating cap-dependent translation are downregulated during total knee arthroplasty.

Authors:  Stephen M Ratchford; Ashley N Bailey; Hilary A Senesac; Austin D Hocker; Keith Smolkowski; Brick A Lantz; Brian A Jewett; Jeffrey S Gilbert; Hans C Dreyer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-28       Impact factor: 3.619

2.  Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development.

Authors:  Takeshi Ueda; Rie Watanabe-Fukunaga; Hidehiro Fukuyama; Shigekazu Nagata; Rikiro Fukunaga
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

3.  Regulation of protein synthesis by eIF4E phosphorylation in adult cardiocytes: the consequence of secondary structure in the 5'-untranslated region of mRNA.

Authors:  William J Tuxworth; Atif N Saghir; Laura S Spruill; Donald R Menick; Paul J McDermott
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

4.  Role of the 5'-untranslated region in regulating translational efficiency of specific mRNAs in adult cardiocytes.

Authors:  Laura S Spruill; Paul J McDermott
Journal:  FASEB J       Date:  2009-05-05       Impact factor: 5.191

Review 5.  Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation?

Authors:  Gert C Scheper; Christopher G Proud
Journal:  Eur J Biochem       Date:  2002-11

Review 6.  Translation initiation of viral mRNAs.

Authors:  Marcelo López-Lastra; Pablo Ramdohr; Alejandro Letelier; Maricarmen Vallejos; Jorge Vera-Otarola; Fernando Valiente-Echeverría
Journal:  Rev Med Virol       Date:  2010-05       Impact factor: 6.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.